How long can you live with metastatic triple negative breast cancer?
Median survival with MBC was 13.3 months (range, 0.8-99.8 months). Median duration of first-line palliative therapy was 11.9 weeks (range, 0-73.1 weeks).
What are the chances of recurrence of triple negative breast cancer?
Recurrence Rates According to a 2019 study, around 40% of people who have stage 1 to stage 3 triple-negative breast cancer will have a recurrence following standard treatment, while around 60% will have long-term disease-free survival.
What stage of cancer is triple negative?
On a scale of 1 to 3, triple-negative breast cancer often is grade 3. It usually is a cell type called “basal-like.” “Basal-like” means that the cells resemble the basal cells that line the breast ducts. Basal-like cancers tend to be more aggressive, higher grade cancers — just like triple-negative breast cancers.
What is the longest survival rate for triple negative BC?
5-year relative survival rates for triple-negative breast cancer
| SEER Stage | 5-year Relative Survival Rate |
|---|---|
| Localized | 91% |
| Regional | 65% |
| Distant | 12% |
| All stages combined | 77% |
Can TNBC be cured?
It may be treatable, but it’s usually not curable. TNBC has a high recurrence rate, which is greatest within the first 3 years. However, there’s a sharp reduction in recurrence after 5 years. Therefore, there are no long post-therapy regimens.
What does it mean to have triple negative breast cancer?
Triple-negative breast cancer is cancer that tests negative for estrogen receptors, progesterone receptors, and excess HER2 protein. These results mean the growth of the cancer is not fueled by the hormones estrogen and progesterone, or by the HER2 protein. So, triple-negative breast cancer does not respond to hormonal therapy medicines or
Where can I find articles about triple-negative breast cancer?
Based on your unique information, Breastcancer.org can recommend articles that are highly relevant to your situation. Triple-negative breast cancer is cancer that tests negative for estrogen receptors, progesterone receptors, and excess HER2 protein.
What are the treatment options for triple negative breast cancer?
Treatment for triple-negative breast cancer Triple-negative breast cancer is typically treated with a combination of surgery, radiation therapy, and chemotherapy.
What is the prognosis of triple-negative breast cancer?
Triple-negative breast cancer is considered to be more aggressive and have a poorer prognosis than other types of breast cancer, mainly because there are fewer targeted medicines that treat triple-negative breast cancer.